Interestingly, in this study, analysis of more than 50 HNSCC patient samples evidenced that NEFL promoter hypermethylation predicted diminished OS and disease-free survival in patients treated with cisplatin-based chemotherapy (25). Here, NEFL is linked to head and neck squamous cell carcinoma.